A proliferation‐inducing ligand–mediated anti‐inflammatory response of astrocytes in multiple sclerosis-Reference-Cited by-同舟云学术

A proliferation‐inducing ligand–mediated anti‐inflammatory response of astrocytes in multiple sclerosis

Published:2019-02-04 Issue: Volume: Page:
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Baert Laurie¹,Benkhoucha Mahdia²,Popa Natalia³,Ahmed Mashal C.¹,Manfroi Benoit¹,Boutonnat Jean⁴,Sturm Nathalie⁴,Raguenez Gilda³,Tessier Marine³,Casez Olivier⁵,Marignier Romain⁶,Ahmadi Mitra⁷,Broisat Alexis⁷,Ghezzi Catherine⁷,Rivat Cyril⁸,Sonrier Corinne⁸,Hahne Michael⁹,Baeten Dominique¹⁰¹¹,Vives Romain R.¹²,Lortat‐Jacob Hugues¹²,Marche Patrice N.¹^ORCID,Schneider Pascal¹³,Lassmann Hans P.¹⁴,Boucraut Jose³,Lalive Patrice H.²¹⁵,Huard Bertrand¹

Affiliation:

1. Institute for Advanced BiosciencesGrenoble Alpes University/National Institute of Health and Medical Research U1209/National Center for Scientific Research UMR5309 La Tronche France

2. Department of Pathology and Immunology, School of MedicineUniversity of Geneva Geneva Switzerland

3. CRN2M, National Center for Scientific Research UMR6231, Medicine FacultyMediterranean University Marseille France

4. Department of Anatomopathology and CytologyUniversity Hospital Grenoble France

5. Department of NeurologyUniversity Hospital Grenoble France

6. Neuroinflammation and Neuro‐Oncology Team, Faculty of Medicine LaennecLyon Neurosciences Research Center Lyon France

7. Bioclinical RadiopharmaceuticalsNational Institute of Health and Medical Research U1309 Grenoble France

8. Neurosciences InstituteNational Institute of Health and Medical Research U1051 Montpellier France

9. Institute for Molecular GeneticsNational Center for Scientific Research UMR5535 Montpellier France

10. Department of Clinical Immunology and Rheumatology, Academic Medical CenterUniversity of Amsterdam the Netherlands

11. Department of Experimental Immunology, Academic Medical CenterUniversity of Amsterdam Amsterdam the Netherlands

12. Institute of Structural Biology, Grenoble Alpes University, UMR5075National Center for Scientific Research Grenoble France

13. Department of BiochemistryUniversity of Lausanne Épalinges Switzerland

14. Center for Brain ResearchMedical University of Vienna Vienna Austria

15. Department of NeurosciencesDivision of Neurology, Geneva University Hospital Switzerland

Funder

Agence Nationale de la Recherche

Institut National de la Santé et de la Recherche Médicale

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Schweizerische Multiple Sklerose Gesellschaft

Université Grenoble Alpes

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.25415

Reference44 articles.

1. B‐cell targeted therapies in human autoimmune diseases: an updated perspective;Townsend MJ;Immunol Rev,2010

2. Atacicept in multiple sclerosis (ATAMS): a randomised, placebo‐controlled, double‐blind, phase 2 trial;Kappos L;Lancet Neurol,2014

3. APRIL and TALL‐I and receptors BCMA and TACI: system for regulating humoral immunity;Yu G;Nat Immunol,2000

4. ATON: results from a phase II randomized trial of the B‐cell‐targeting agent atacicept in patients with optic neuritis;Sergott RC;J Neurol Sci,2015

5. Treatment with atacicept enhances neuronal cell death in a rat model of optic neuritis;Kretzschmar B;J Neuroimmunol,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chondroitin sulfate proteoglycan promotes APRIL‐induced tumor cell proliferation;Proteoglycan Research;2024-01

2. B-cell activating factor gene variants in multiple sclerosis: Possible associations with disease susceptibility among females;Clinical Immunology;2023-12

3. The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion?;International Journal of Molecular Sciences;2023-07-05

4. Features of Isoforms of Human Soluble TACI;The Journal of Immunology;2023-06-05

5. BAFF and APRIL counterregulate susceptibility to inflammation-induced preterm birth;Cell Reports;2023-04